Patients
Leap Therapeutics is a patient focused company.
We've all known someone important to us, a family member, friend, or co-worker, who has fought cancer. We admire the commitment of all of the patients who choose to enroll in clinical trials. We appreciate the dedication of the doctors, nurses, staff, and patient advocacy groups that support cancer patients and their loved ones. We work every day to develop new targeted therapies for cancer patients.
Click below to learn more about our clinical trials and for links to resources for patients.
Trial number | Indication | Therapy | Trial name |
---|---|---|---|
NCT04363801 | Gastroesophageal cancer |
DKN-01 + tislelizumab + CAPOX DKN-01 + tislelizumab + chemotherapy |
DisTinGuish |
NCT04166721 | Gastroesophageal cancer |
DKN-01 + Tecentriq® + chemotherapy |
WaKING |
NCT05480306 | Colorectal cancer |
DKN-01 + bevacizumab + chemotherapy |
DeFianCe |
NCT05761951 | Endometrial сancer | DKN-01 + Keytruda® | |
NCT05153096 | Claudin18.2 expressing solid tumors | NBL-015 (FL-301) |